EMERGING TRANSPLANT INFECTIONS. CLINICAL CHALLENGES AND IMPLICATIONS (PRINT + E-BOOK)

• Part I: General introduction
1. Infectious Diseases - impact of infections on transplant morbidity/mortality, data on ID impact on outcomes, and important role of Infectious Disease providers in the transplant team
2. Intro to Solid Organ Transplant
3. Intro to Stem Cell Transplantation
4. General concepts
5. Hospital epi / InfControl issues
6. Antibiotic Stewardship for transplant ID
7. Prophylaxis in the era of emerging new infectious pathogens
8. Pre-transplant evaluation of patients with MDRO infection/colonization
9. Pre-transplant screening of patients with epidemiologic & geographic risk factors for infection exposure
10. Safe living post-transplant
11. Vaccination
12. Travel medicine and the Transplant Recipient - Infection Avoidance & Management of the Returning Traveler with Fever including Transplant Tourism
13. Changing definition of Immunosuppression - Biologics, Monoclonal Antibodies - what infections will emerge as a result and how do we prevent them?
• Part II: Bacterial Infections Introduction
14. Multidrug Resistant Organisms including Extended Spectrum Beta Lactamase Producing Organisms & Carbapenemase Resistant Enterobacteriaceae
15. Mycobacterium tuberculosis
16. Rapidly Growing Nontuberculous Mycobacteria
17. Slow Growing Nontuberculous Mycobacteria - M. Chimaera
18. Nocardia
19. Mycoplasma / Ureaplasma
20. Pseudomonas including Pseudomonas pseudomallei
21. Acinetobacter
22. Burkholderia
23. Clostridia Difficile
• Part III: Viral Infections Introduction
24. Cytomegalovirus
25. Herpes Simplex
26. Varicella Zoster
27. Epstein Barr Virus including PTLD
28. HHV6, HHV7, HHV8
29. BK VIrus
30. Influenza
31. Respiratory Syncytial Virus
32. Respiratory viruses including parainfluenza, metapneumovirus, rhinovirus, enterovirus, coronaviruses (MERS CoV & SARS)
33. Adenovirus
34. HIV
35. Hepatitis A & E
36. Hepatitis B & D
37. Hepatitis C
38. West Nile Virus
39. Dengue, Chikungunya, & Zika
40. Yellow Fever
41. Viral Encephalitides including Rabies & Lymphocytic Choriomeningitis Virus
• Part IV: Fungal Infections Introduction
42. Candida
43. Aspergillus
44. Mucorales
45. Non-Aspergillus Molds esp. Phaeohyphomycoses
46. Cryptococcus including gatti
47. Pneumocystis
48. Endemic molds - coccidioidomycosis, histoplasmosis, blastomycosis, paracoccidioidomycosis
• Part V: Parasitic Infections Introduction
49. Toxoplasmosis
50. Strongyloidiasis
51. Chagas disease
52. Leishmaniasis
53. Malaria
54. Entamoeba histolytica
55. Intestinal Parasites including Cryptosporidium, Cyclospora, Microsporidia, Blastocystis hominis, Isospora, Giardia
56. Acanthamoeba, Naegleria, & Balamuthia
• Part VI: Emerging Clinical Challenges
57. Ventricular Assist Devices/ECMO/Cardiac Support

The field of transplant medicine has evolved significantly since the first kidney transplant was performed in 1954. Innovations in transplant immunosuppression have lowered the risk of organ rejection so that infectious complications are now the leading cause of hospitalization and mortality after solid organ transplant. Infection is also cited as the leading cause of non-relapse mortality after stem cell transplantation. As transplant centers have recognized the importance of transplant specific expertise in patient outcomes, the field of transplant infectious diseases has expanded into a recognized and highly valued subspecialty. International growth in solid organ and stem cell transplantation has outpaced access to such expertise, with some centers employing microbiology laboratory directors and transplant nephrologists as their lead infectious diseases consultants. This has been a particular challenge as the use of novel immunosuppressive regimens in new geographic and immigrant populations have fueled the emergence of new infection syndromes, with the initial presentation sometimes occurring in this most vulnerable patient population.
This digital-first book is designed to meet the needs of practitioners engaged in transplant infectious disease practice who need more depth than they are able to find in UpToDate. It provides an overview of emerging infectious disease challenges with clinically relevant information regarding the epidemiology, diagnosis, management, and prevention of infections in solid organ and stem cell transplant recipients. Each chapter focuses on a clinical syndrome or pathogen with new or emerging implications for transplant patients.
Given the rapidly evolving nature of emerging infections and topics in transplant infections, no resource has been published on these increasingly notorious issues; this this text is written by top, global experts who regularly update the material to ensure that readers will always have access to the most cutting edge material available.
The editorial team consists of three experienced leaders in the field, all of whom have a strong record of scholarship and publication, as well as an international reputation. All three have focused their academic careers on emerging infectious diseases in transplantation, including a current and a past president of various infectious diseases and transplantation societies. The editors are also experienced reviewers and authors who have collaborated on multiple previous projects. All are committed to this project as a unique opportunity to make an important contribution to their field.

Features
• Provides an overview with clinically relevant information
• Includes detailed, clinical guidelines
• Covers clinical syndromes and pathogens with new or emerging implications for transplant patients